<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02014961</url>
  </required_header>
  <id_info>
    <org_study_id>METC 142060</org_study_id>
    <nct_id>NCT02014961</nct_id>
  </id_info>
  <brief_title>Worm Study: Modifier Genes in Sudden Cardiac Death</brief_title>
  <official_title>Worm Study: Identification of Modifier Genes in a Unique Founder Population With Sudden Cardiac Death</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Maastricht University Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Netherlands Heart Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Maastricht University Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Quest for modifier genes associated with ventricular arrhythmias in presence of a cardiac
      sodium channel gene (SCN5A-delPhe1617) mutation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In a large Dutch SCN5A founder population with malignant ventricular arrhythmias, the
      investigators aim to identify genetic modifiers by means of whole-exome sequencing and to
      establish a comprehensive genotype-phenotype correlation, focussing on clinical and cellular
      electrophysiological characteristics and neurocardiac modulation.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2015</start_date>
  <completion_date type="Anticipated">April 2025</completion_date>
  <primary_completion_date type="Anticipated">April 2025</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Difference in genetic profile (e.g. modifier genes) between mutation carriers expressing different phenotypes and non-mutation carriers.</measure>
    <time_frame>two years</time_frame>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">223</enrollment>
  <condition>Brugada Syndrome</condition>
  <condition>Long QT Syndrome 3</condition>
  <arm_group>
    <arm_group_label>Mutation Carriers</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Whole-exome sequencing (WES) Dermal biopsy Gastro-intestinal questionnaire</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-Mutation Carriers</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Whole-exome sequencing (WES) Gastro-intestinal questionnaire</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Spouse</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Whole-exome sequencing (WES) 12-Lead ECG</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Dermal biopsy</intervention_name>
    <description>Skin biopsy</description>
    <arm_group_label>Mutation Carriers</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Gastro-intestinal questionnaire</intervention_name>
    <description>Pagi-Sym, Bristol Stool Chart, gastrointestinal symptom rating scale (GSRS)</description>
    <arm_group_label>Mutation Carriers</arm_group_label>
    <arm_group_label>Non-Mutation Carriers</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Genetic</intervention_type>
    <intervention_name>Whole-exome sequencing</intervention_name>
    <description>Whole-exome sequencing (WES)</description>
    <arm_group_label>Mutation Carriers</arm_group_label>
    <arm_group_label>Non-Mutation Carriers</arm_group_label>
    <arm_group_label>Spouse</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria (mutation carrier group):

          -  Age ≥ 18 years.

          -  Heterozygous or homozygous carriership of SCN5A-delPhe1617.

          -  Confirmed kinship to the founder population by haplotype analysis using predefined
             microsatellite markers.

          -  Written informed consent.

        Inclusion Criteria (non-mutation carrier group):

          -  Age ≥ 18 years.

          -  Non SCN5A-delPhe1617 genotype.

          -  Confirmed kinship to the Founder Group by haplotype analysis using predefined
             microsatellite marker.

          -  Written informed consent.

        Inclusion criteria Spouse Group

          -  Age ≥ 18 years.

          -  Biological parent of SCN5A-delPhe1617 positive subject participating to the Worm
             Study, and not belonging to study group 1 or 2.

          -  Written informed consent.

        Exclusion Criteria:

          -  Age ≥ 18 years.

          -  Biological parent of SCN5A-delPhe1617 positive subject participating to the Worm
             Study, and not belonging to study group 1 or 2.

          -  Written informed consent.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Paul Volders, M.D., Ph.D.</last_name>
    <role>Study Director</role>
    <affiliation>Maastricht University Medical Centre</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Rachel ter Bekke, M.D.</last_name>
    <phone>+31433877098</phone>
    <email>rachel.ter.bekke@mumc.nl</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Paul Volders, M.D., Ph.D.</last_name>
    <phone>+31433877097</phone>
    <email>p.volders@maastrichtuniversity.nl</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Maastricht University Medical Center</name>
      <address>
        <city>Maastricht</city>
        <state>Limburg</state>
        <zip>6202 AZ</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>ter Bekke</last_name>
      <phone>+31433877098</phone>
      <email>rachel.ter.bekke@mumc.nl</email>
    </contact>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>May 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 9, 2013</study_first_submitted>
  <study_first_submitted_qc>December 12, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 19, 2013</study_first_posted>
  <last_update_submitted>May 13, 2015</last_update_submitted>
  <last_update_submitted_qc>May 13, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 14, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Death</mesh_term>
    <mesh_term>Death, Sudden, Cardiac</mesh_term>
    <mesh_term>Long QT Syndrome</mesh_term>
    <mesh_term>Brugada Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

